General Information of Drug (ID: DM10PLO)

Drug Name
VLA1601
Indication
Disease Entry ICD 11 Status REF
Zika virus infection 1D48 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DCL84J

References

1 ClinicalTrials.gov (NCT03425149) Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults. U.S. National Institutes of Health.